Spokesperson Andrea Rader pointed to economic uncertainty and competition from other charities as a factor in the decision, which "was not made lightly," according to a statement on the charity's Facebook page. The statement added, "Many participants have reported that enthusiasm for the series remains very high, but it is more difficult for people to donate at levels they had in the past."
The Post notes that Komen's annual Race for the Cure in Washington, D.C., has lost participants in recent years: About 21,000 attended the race in 2013, down from 27,000 last year and 40,000 in 2011. Fundraising also spiraled over the past four years: The D.C. race raised $1.5 million this year, down from $2 million last year and $5 million in 2011.
But Avon's numbers suggest that Komen's decline may be about more than just the economy. The Avon Walk for Breast Cancer will take place in the same eight cities as the organization's 2013 events, according to an Avon spokesperson. The company fundraised $4.5 million for this year's race, compared with $5 million the year before.
On the Advisory Board blogs
- Care Transformation Center Blog: Bonnie Jin profiles a health network that reduced Medicare readmissions to 1.62% by employing veteran medics as transition coaches.
- Cardiovascular Rounds: Jeffrey Rakover explains how Boston Children's Hospital uses instances of clinical variation to inform changes to its care pathways.
- Care Transformation Center Blog: Cabell Jonas and Yulan Egan offer three tipsfor simplifying care for medically-complex children.